Keisuke Watanabe

6PUBLICATIONS
48CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 12, 2026
Reinvigorating the Cancer-Immunity Cycle With Combined Oncolytic Virus and CAR-T Cell Therapies in Solid Tumors.

|Apr 15, 2026
On-demand GLUT3 expression augments CAR T cell metabolic fitness and antitumor efficacy in preclinical models of glioblastoma.

|Apr 07, 2026
Ponatinib inhibits LCK and PI3K signaling and promotes CD8+ T stem cell memory cell development.

Yuki Okuhiro, Sachiko Ito, Keisuke Watanabe

|Feb 12, 2025
Coactivation of innate immune suppressive cells induces acquired resistance against combined TLR agonism and PD-1 blockade.

Hitomi Nishinakamura, Sayoko Shinya, Takuma Irie

|Oct 11, 2023
Phase II Trial of Nivolumab in Metastatic Rare Cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial).

Hitomi S Okuma, Keisuke Watanabe, Kenji Tsuchihashi

|Dec 05, 2022
The cancer epigenome: Non-cell autonomous player in tumor immunity.

Shinichiro Kato, Yuka Maeda, Daisuke Sugiyama

Pageof 1

Frequent Collaborators

5 joint publications

Hiroyoshi Nishikawa

2 joint publications

Shohei Koyama

2 joint publications

Daisuke Sugiyama

2 joint publications

Hitomi Nishinakamura